Based on American Society of Clinical Oncology guidelines [36], estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) are the recommended tumor marker tests for the prevention, screening, and treatment of BC. This evidence concerns the gene ESR1 and neoplasm.